Form D · Biotechnology
Valid Inc.
Wayland, MA · CIK 0002052714
Offering snapshot reported Jan 22, 2025 · SEC filing
- Reported sold
- $6.86M Offering amount: $6.86M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 22, 2025 | Initial | $6,861,790 | No comparison | 15 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-535851
Total offering amount and the total amount sold include the conversion of $361,800 of outstanding convertible securities.
Source: Form D, filed Jan 22, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Tim Ahfeldt | Director, Executive |
| Joshua Lamstein | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
8 Springhill Road
Wayland, MA, 01778
Wayland, MA, 01778